Boulos A, Maroun D, Ciechanover A, Ziv N
Commun Biol. 2024; 7(1):1014.
PMID: 39155290
PMC: 11330980.
DOI: 10.1038/s42003-024-06733-1.
Costa R, Conceicao A, Matos C, Nobrega C
Cell Death Dis. 2024; 15(6):415.
PMID: 38877004
PMC: 11178924.
DOI: 10.1038/s41419-024-06812-5.
Arning L, Nguyen H
Med Genet. 2024; 33(4):293-300.
PMID: 38835439
PMC: 11006308.
DOI: 10.1515/medgen-2021-2101.
Tanudisastro H, Deveson I, Dashnow H, MacArthur D
Nat Rev Genet. 2024; 25(7):460-475.
PMID: 38366034
DOI: 10.1038/s41576-024-00692-3.
Hnath B, Chen J, Reynolds J, Choi E, Wang J, Zhang D
Protein Sci. 2023; 32(7):e4686.
PMID: 37243896
PMC: 10273386.
DOI: 10.1002/pro.4686.
Low XIST expression in Sertoli cells of Klinefelter syndrome patients causes high susceptibility of these cells to an extra X chromosome.
Zhao L, Li P, Yao C, Tian R, Tang Y, Chen Y
Asian J Androl. 2023; 25(6):662-673.
PMID: 37202929
PMC: 10715603.
DOI: 10.4103/aja202315.
Native functions of short tandem repeats.
Wright S, Todd P
Elife. 2023; 12.
PMID: 36940239
PMC: 10027321.
DOI: 10.7554/eLife.84043.
A peptide inhibitor that rescues polyglutamine-induced synaptic defects and cell death through suppressing RNA and protein toxicities.
Peng S, Leong L, Sun J, Chen Z, Chow H, Chan H
Mol Ther Nucleic Acids. 2022; 29:102-115.
PMID: 35795484
PMC: 9240964.
DOI: 10.1016/j.omtn.2022.06.004.
PQBP1: The Key to Intellectual Disability, Neurodegenerative Diseases, and Innate Immunity.
Tanaka H, Okazawa H
Int J Mol Sci. 2022; 23(11).
PMID: 35682906
PMC: 9180999.
DOI: 10.3390/ijms23116227.
Analysis of Huntington's Disease Modifiers Using the Hyperbolic Mapping of the Protein Interaction Network.
Vagiona A, Mier P, Petrakis S, Andrade-Navarro M
Int J Mol Sci. 2022; 23(10).
PMID: 35628660
PMC: 9144261.
DOI: 10.3390/ijms23105853.
Impact of ER Stress and ER-Mitochondrial Crosstalk in Huntington's Disease.
Maity S, Komal P, Kumar V, Saxena A, Tungekar A, Chandrasekar V
Int J Mol Sci. 2022; 23(2).
PMID: 35054963
PMC: 8775980.
DOI: 10.3390/ijms23020780.
Molecular mechanisms underlying nucleotide repeat expansion disorders.
Malik I, Kelley C, Wang E, Todd P
Nat Rev Mol Cell Biol. 2021; 22(9):589-607.
PMID: 34140671
PMC: 9612635.
DOI: 10.1038/s41580-021-00382-6.
Slc1a3-2A-CreERT2 mice reveal unique features of Bergmann glia and augment a growing collection of Cre drivers and effectors in the 129S4 genetic background.
Kaczmarczyk L, Reichenbach N, Blank N, Jonson M, Dittrich L, Petzold G
Sci Rep. 2021; 11(1):5412.
PMID: 33686166
PMC: 7940647.
DOI: 10.1038/s41598-021-84887-2.
Phase Transition of Huntingtin: Factors and Pathological Relevance.
Yang J, Yang X
Front Genet. 2020; 11:754.
PMID: 32849783
PMC: 7396480.
DOI: 10.3389/fgene.2020.00754.
Truncation of mutant huntingtin in knock-in mice demonstrates exon1 huntingtin is a key pathogenic form.
Yang H, Yang S, Jing L, Huang L, Chen L, Zhao X
Nat Commun. 2020; 11(1):2582.
PMID: 32444599
PMC: 7244548.
DOI: 10.1038/s41467-020-16318-1.
New pathologic mechanisms in nucleotide repeat expansion disorders.
Rodriguez C, Todd P
Neurobiol Dis. 2019; 130:104515.
PMID: 31229686
PMC: 6689435.
DOI: 10.1016/j.nbd.2019.104515.
Ubiquitin-Proteasome System in Neurodegenerative Disorders.
Rao G, Croft B, Teng C, Awasthi V
J Drug Metab Toxicol. 2019; 6(4).
PMID: 30761219
PMC: 6370320.
DOI: 10.4172/2157-7609.1000187.
Studying Huntington's Disease in Yeast: From Mechanisms to Pharmacological Approaches.
Hofer S, Kainz K, Zimmermann A, Bauer M, Pendl T, Poglitsch M
Front Mol Neurosci. 2018; 11:318.
PMID: 30233317
PMC: 6131589.
DOI: 10.3389/fnmol.2018.00318.
Polyglutamine Repeats in Neurodegenerative Diseases.
Lieberman A, Shakkottai V, Albin R
Annu Rev Pathol. 2018; 14:1-27.
PMID: 30089230
PMC: 6387631.
DOI: 10.1146/annurev-pathmechdis-012418-012857.
Tissue-Specific Upregulation of Drosophila Insulin Receptor (InR) Mitigates Poly(Q)-Mediated Neurotoxicity by Restoration of Cellular Transcription Machinery.
Raj K, Sarkar S
Mol Neurobiol. 2018; 56(2):1310-1329.
PMID: 29881950
DOI: 10.1007/s12035-018-1160-3.